Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Sost Biotech Co., Ltd., founded in 2004, is a leading Chinese biotechnology manufacturer specializing in the research, development, and production of natural ingredients and active pharmaceutical ingredients (APIs). Headquartered in Xi'an, the company operates extensive organic cultivation bases and GMP-certified facilities to produce high-quality botanical extracts, including Reishi mushroom, sulforaphane, and pterostilbene. Its product portfolio serves diverse sectors such as pharmaceuticals, nutraceuticals, and cosmetics in over 80 countries worldwide. Sost Biotech utilizes advanced manufacturing technologies like supercritical CO2 extraction and microencapsulation to ensure product stability and efficacy. The company is committed to the development of 'green products' for human health, supporting applications in inflammation, metabolic health, and anti-aging. With a PhD-led R&D team and numerous patents, it continues to innovate in the field of high-purity natural products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sost Biotech.